4LWU | The 1.14A Crystal Structure of Humanized Xenopus MDM2 with RO5499252 | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Graves, B.J., Lukacs, C., Janson, C.A. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.14 | ||||||||||||
ligand | 20U, SO4 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy., Zhang Z, Ding Q, Liu JJ, Zhang J, Jiang N, Chu XJ, Bartkovitz D, Luk KC, Janson C, Tovar C, Filipovic ZM, Higgins B, Glenn K, Packman K, Vassilev LT, Graves B, Bioorg Med Chem. 2014 Jun 11. pii: S0968-0896(14)00431-3. doi:, 10.1016/j.bmc.2014.05.072. PMID:24997575 |
Data retrieval |
View 4LWU in 3D |
Visual 3D analysis of 4LWU |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4LWU |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |